243 related articles for article (PubMed ID: 17173074)
1. Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicity.
Ma Y; Cress WD
Oncogene; 2007 May; 26(24):3532-40. PubMed ID: 17173074
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
[TBL] [Abstract][Full Text] [Related]
3. CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P.
Mitra P; Ghule PN; van der Deen M; Medina R; Xie RL; Holmes WF; Ye X; Nakayama KI; Harper JW; Stein JL; Stein GS; van Wijnen AJ
J Cell Physiol; 2009 May; 219(2):438-48. PubMed ID: 19170105
[TBL] [Abstract][Full Text] [Related]
4. Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence.
Tsugu A; Sakai K; Dirks PB; Jung S; Weksberg R; Fei YL; Mondal S; Ivanchuk S; Ackerley C; Hamel PA; Rutka JT
Am J Pathol; 2000 Sep; 157(3):919-32. PubMed ID: 10980131
[TBL] [Abstract][Full Text] [Related]
5. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
Figliola R; Busanello A; Vaccarello G; Maione R
J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
[TBL] [Abstract][Full Text] [Related]
6. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of the p57-E2F1-p53 axis results in nonobstructive hydrocephalus and cerebellar malformation in mice.
Matsumoto A; Susaki E; Onoyama I; Nakayama K; Hoshino M; Nakayama KI
Mol Cell Biol; 2011 Oct; 31(20):4176-92. PubMed ID: 21844226
[TBL] [Abstract][Full Text] [Related]
8. CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner.
Ma Y; Chen L; Wright GM; Pillai SR; Chellappan SP; Cress WD
J Biol Chem; 2010 Mar; 285(13):9813-9822. PubMed ID: 20106982
[TBL] [Abstract][Full Text] [Related]
9. E2F1-mediated upregulation of p19INK4d determines its periodic expression during cell cycle and regulates cellular proliferation.
Carcagno AL; Marazita MC; Ogara MF; Ceruti JM; Sonzogni SV; Scassa ME; Giono LE; Cánepa ET
PLoS One; 2011; 6(7):e21938. PubMed ID: 21765927
[TBL] [Abstract][Full Text] [Related]
10. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
Hattori N; Davies TC; Anson-Cartwright L; Cross JC
Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
[TBL] [Abstract][Full Text] [Related]
11. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract][Full Text] [Related]
12. CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma.
Giovannini C; Gramantieri L; Minguzzi M; Fornari F; Chieco P; Grazi GL; Bolondi L
Am J Pathol; 2012 Aug; 181(2):413-22. PubMed ID: 22705236
[TBL] [Abstract][Full Text] [Related]
13. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
14. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
15. The E2A splice variant E47 regulates the differentiation of projection neurons via p57(KIP2) during cortical development.
Pfurr S; Chu YH; Bohrer C; Greulich F; Beattie R; Mammadzada K; Hils M; Arnold SJ; Taylor V; Schachtrup K; Uhlenhaut NH; Schachtrup C
Development; 2017 Nov; 144(21):3917-3931. PubMed ID: 28939666
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of the CDK inhibitor p21
Kurayoshi K; Shiromoto A; Ozono E; Iwanaga R; Bradford AP; Araki K; Ohtani K
Biochem Biophys Res Commun; 2017 Jan; 483(1):107-114. PubMed ID: 28042030
[TBL] [Abstract][Full Text] [Related]
17. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
19. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
Johnson DG
Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
[TBL] [Abstract][Full Text] [Related]
20. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]